Galectin Therapeutics (GALT) Receivables - Other (2011)
Galectin Therapeutics' (GALT) quarterly Receivables - Other came in at -$234000.0 in Q1 2011.
Galectin Therapeutics (GALT) Receivables - Other (2011) Analysis & Trends
Galectin Therapeutics' Receivables - Other history runs 1 years deep, the most recent figure standing at -$234000.0 for Q1 2011.
- On a quarterly basis, Receivables - Other changed N/A year-over-year to -$234000.0 in Q1 2011; TTM through Dec 2011 was -$234000.0, a N/A change from a year earlier, with the FY2011 full-year figure at -$234000.0, down 200.0% from the prior year.
- Receivables - Other was little changed at -$234000.0 in Q1 2011 per GALT's latest filing.
- Across five years, Receivables - Other topped out at -$234000.0 in Q1 2011 and bottomed at -$234000.0 in Q1 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Galectin Therapeutics | 227.21 Mn | 227.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2011 | -234,000.00 |
| Mar 31, 2011 | -234,000.00 |